Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LINAGLIPTIN Cause International normalised ratio increased? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of International normalised ratio increased have been filed in association with LINAGLIPTIN (Linagliptin and metformin hydrochloride). This represents 0.1% of all adverse event reports for LINAGLIPTIN.

8
Reports of International normalised ratio increased with LINAGLIPTIN
0.1%
of all LINAGLIPTIN reports
1
Deaths
5
Hospitalizations

How Dangerous Is International normalised ratio increased From LINAGLIPTIN?

Of the 8 reports, 1 (12.5%) resulted in death, 5 (62.5%) required hospitalization.

Is International normalised ratio increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LINAGLIPTIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does LINAGLIPTIN Cause?

Blood glucose increased (804) Dyspnoea (571) Dizziness (529) Pruritus (527) Nausea (525) Diarrhoea (509) Vomiting (465) Fatigue (464) Malaise (457) Arthralgia (446)

What Other Drugs Cause International normalised ratio increased?

WARFARIN (5,622) RIVAROXABAN (863) ACETAMINOPHEN (533) ASPIRIN (448) APIXABAN (317) CLOPIDOGREL BISULFATE (314) FLUINDIONE (286) AMIODARONE (277) FUROSEMIDE (277) DABIGATRAN ETEXILATE (223)

Which LINAGLIPTIN Alternatives Have Lower International normalised ratio increased Risk?

LINAGLIPTIN vs LINAGLIPTIN\METFORMIN LINAGLIPTIN vs LINCOMYCIN LINAGLIPTIN vs LINEZOLID LINAGLIPTIN vs LINZESS LINAGLIPTIN vs LIORESAL

Related Pages

LINAGLIPTIN Full Profile All International normalised ratio increased Reports All Drugs Causing International normalised ratio increased LINAGLIPTIN Demographics